14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
GMED | US$92.84 | 2.2% | 72.7% | US$12.6b | US$97.85 | PE138.1x | E49.1% | n/a | ||
FRE | €36.72 | 1.2% | 36.3% | €20.7b | €41.66 | PS0.9x | E37.1% | n/a | ||
SOON | CHF 319.70 | 5.7% | 14.8% | CHF 19.1b | CHF 300.89 | PE33.7x | E10.3% | 1.3% | ||
PHIA | €25.61 | 2.0% | 25.8% | €23.9b | €28.78 | PS1.3x | E63.0% | n/a | ||
PUREHEALTH | د.إ3.59 | -2.2% | -23.1% | د.إ39.9b | د.إ5.33 | PE35.5x | E34.2% | n/a | ||
LH | US$246.00 | 3.1% | 9.4% | US$20.4b | US$261.36 | PE47.2x | E22.4% | 1.2% | ||
4013 | ر.س292.00 | 0.3% | -1.2% | ر.س102.2b | ر.س306.83 | PE45.9x | E13.7% | 1.5% | ||
BIM | €112.70 | 1.9% | 7.4% | €13.3b | €120.73 | PE32.3x | E13.6% | 0.8% | ||
RDOR3 New | R$28.01 | 4.9% | 1.6% | R$62.1b | R$38.13 | PE17.4x | E16.6% | 1.1% | ||
DXCM | US$88.75 | 5.2% | -27.2% | US$34.3b | US$96.26 | PE50.9x | E16.1% | n/a | ||
7733 | JP¥2,308.50 | 0.8% | 6.4% | JP¥2.6t | JP¥3,022.86 | PE29.7x | E13.7% | 0.9% | ||
7741 | JP¥21,290.00 | 3.8% | 17.0% | JP¥7.4t | JP¥23,184.38 | PE37.6x | E11.4% | 0.5% | ||
MOH | US$304.33 | 6.3% | -13.9% | US$17.5b | US$357.67 | PE15.2x | E13.5% | n/a | ||
SN. | UK£10.03 | -2.2% | -9.3% | UK£8.7b | UK£12.56 | PE35.8x | E22.6% | 3.0% |
Page 1 of 1